INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Goodwill in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Integra Lifesciences Holdings Corp quarterly Goodwill history and growth rate from Q2 2010 to Q2 2024.
  • Integra Lifesciences Holdings Corp Goodwill for the quarter ending June 30, 2024 was $1.1B, a 5.88% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.1B +$61.4M +5.88% Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $1.04B -$1.37M -0.13% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.06B +$16.6M +1.6% Dec 31, 2023 10-Q 2024-07-29
Q3 2023 $1.04B +$58.3M +5.96% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 $1.04B +$52.9M +5.34% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $1.04B +$32.7M +3.24% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 $1.04B +$25.4M +2.51% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $978M -$34.2M -3.38% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $990M -$25.2M -2.48% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $1.01B -$1.14M -0.11% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 $1.01B +$81.1M +8.7% Dec 31, 2021 10-K 2024-02-28
Q3 2021 $1.01B +$92.5M +10.1% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $1.02B +$59.4M +6.22% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $1.01B +$58.5M +6.15% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $932M -$21.9M -2.3% Dec 31, 2020 10-K 2023-02-22
Q3 2020 $920M -$25.7M -2.72% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $956M +$29.5M +3.18% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $952M +$29M +3.15% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $954M +$27.8M +3% Dec 31, 2019 10-K 2022-02-24
Q3 2019 $945M +$18.9M +2.04% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $927M -$416K -0.05% Jun 30, 2019 10-Q 2019-07-25
Q1 2019 $923M -$22M -2.33% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $926M -$11.4M -1.22% Dec 31, 2018 10-K 2021-02-23
Q3 2018 $926M +$338M +57.6% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $927M +$342M +58.4% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $944M +$366M +63.3% Mar 31, 2018 10-Q 2018-04-26
Q4 2017 $938M +$427M +83.7% Dec 31, 2017 10-K 2020-02-21
Q3 2017 $588M +$72.3M +14% Sep 30, 2017 10-Q 2017-10-26
Q2 2017 $585M +$71.4M +13.9% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $578M +$62.1M +12% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $511M -$1.82M -0.36% Dec 31, 2016 10-K 2019-02-26
Q3 2016 $516M +$9.91M +1.96% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $514M +$157M +44% Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $516M +$162M +45.7% Mar 31, 2016 10-Q 2016-04-27
Q4 2015 $512M +$149M +41% Dec 31, 2015 10-K 2018-03-01
Q3 2015 $506M +$156M +44.7% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $357M +$2.05M +0.58% Jun 30, 2015 10-Q 2015-07-31
Q1 2015 $354M -$13.4M -3.66% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 $363M +$114M +45.5% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $350M +$101M +40.5% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $355M +$62.1M +21.2% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $368M +$75.4M +25.8% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $250M -$44.3M -15.1% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $249M -$43.6M -14.9% Sep 30, 2013 10-Q 2013-10-30
Q2 2013 $293M +$796K +0.27% Jun 30, 2013 10-Q/A 2013-08-02
Q1 2013 $292M -$2.95M -1% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $294M +$1.09M +0.37% Dec 31, 2012 8-K 2014-06-20
Q3 2012 $292M -$2.1M -0.71% Sep 30, 2012 10-Q 2012-10-24
Q2 2012 $292M +$6.71M +2.35% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 $295M +$27.8M +10.4% Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $293M +$31.1M +11.9% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $295M +$32.1M +12.2% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $285M +$33.2M +13.2% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 $267M Mar 31, 2011 10-Q 2011-04-28
Q4 2010 $262M Dec 31, 2010 10-K 2012-02-27
Q3 2010 $262M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 $252M Jun 30, 2010 10-Q 2010-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.